Critical Overview of Molecular Insights into Osteoarthritis and Therapeutic Targets: Cytokines, RANKL, MMPs, Adipokines and Phosphate Dysregulation
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27125292 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Mikołaj Bugajewski und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Immunology Student Scientific Association, Medical University of Warsaw, Nowogrodzka 59, 02-006 Warsaw, Poland. Hauptthemen laut MEDLINE: Osteoarthritis, RANK Ligand, Matrix Metalloproteinases, Cytokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteoarthritis (OA) is a highly prevalent joint disorder traditionally considered a consequence of mechanical cartilage wear; however, it is now recognized as a complex, multifactorial disease driven by interconnected molecular and cellular mechanisms. This narrative review synthesizes current knowledge on key pathogenic pathways underlying OA progression, with a focus on inflammatory signaling, subchondral bone remodeling, and dysregulation of mineral metabolism. Chronic low-grade inflammation promotes catabolic responses in chondrocytes and contributes to cartilage degradation. In addition, obesity influences OA pathogenesis through both biomechanical loading and adipokine-mediated inflammatory mechanisms. Alterations in the receptor activator of nuclear factor kappa-B/receptor activator of nuclear factor kappa-B ligand/osteoprotegerin (RANK/RANKL/OPG) axis disrupt bone homeostasis and promote pathological subchondral remodeling, while imbalances in inorganic phosphate metabolism contribute to crystal deposition and further joint damage. These processes interact synergistically, driving disease progression. Current therapeutic strategies remain largely symptomatic and do not adequately target underlying molecular drivers. A deeper understanding of these mechanisms may facilitate the development of disease-modifying therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Immunology Student Scientific Association, Medical University of Warsaw, Nowogrodzka 59, 02-006 Warsaw, Poland.
- Department of Orthopedics and Rehabilitation, Medical University of Warsaw, 02-091 Warsaw, Poland.
- Department of Clinical Immunology, Medical University of Warsaw, 02-006 Warsaw, Poland.
- Institute of Biochemistry and Biophysics, Polish Academy of Sciences, ul. Pawińskiego 5A, 02-106 Warsaw, Poland.
ORCID-Profile: Mikołaj Bugajewski, Artur Stolarczyk, Jakub Piotr Adamus, Aleksandra Poszytek, Leszek Pączek
Zitieren
APA
Bugajewski, M., Stolarczyk, A., Matysek, M., Adamus, J. P., Poszytek, A., & Pączek, L. (2026). Critical Overview of Molecular Insights into Osteoarthritis and Therapeutic Targets: Cytokines, RANKL, MMPs, Adipokines and Phosphate Dysregulation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27125292
Vancouver
Bugajewski M, Stolarczyk A, Matysek M, Adamus JP, Poszytek A, Pączek L. Critical Overview of Molecular Insights into Osteoarthritis and Therapeutic Targets: Cytokines, RANKL, MMPs, Adipokines and Phosphate Dysregulation. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27125292
BibTeX
@article{Bugajewski2026,
author = {Bugajewski, Mikołaj and Stolarczyk, Artur and Matysek, Maja and Adamus, Jakub Piotr and Poszytek, Aleksandra and Pączek, Leszek},
title = {Critical Overview of Molecular Insights into Osteoarthritis and Therapeutic Targets: Cytokines, RANKL, MMPs, Adipokines and Phosphate Dysregulation},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27125292}
}
EUVIMED